Monica Colvin-Adams, MD

Assistant Professor of Medicine
Advanced Heart Failure, Transplantation, and Mechanical Circulatory Support

Dr. Monica Colvin-Adams was born in Bessemer, Alabama. She received her undergraduate degree from Amherst College, and her M.D. from the University of Alabama. After completing a general-cardiology fellowship at the University of Miami and an advanced heart failure/transplant fellowship at the Cleveland Clinic, she joined the faculty at the University of Minnesota. Since joining the faculty, she has developed and directed the pulmonary-hypertension clinic, and directed the heart-transplant program. In addition, she has participated in multiple clinical research trials in the areas of advanced heart failure, heart transplantation, and pulmonary hypertension.

Dr. Colvin-Adams is the recipient of a Career Advancement Program Scholarship, which provides NIH funding to conduct investigator-initiated research. Her current research focuses on developing strategies to improve post-transplant outcomes, including detecting and treating cardiac allograft vasculopathy. In addition, she is completing a master’s degree in clinical research.

Dr. Colvin-Adams provides care for advanced heart-failure patients (including patients with mechanical circulatory support) and heart-transplant recipients.

Professional Organizations

• American College of Cardiology, member
• American Heart Association, member
• AHA Committee on Heart Failure and Transplantation
• Association of Black Cardiologists, member
• Heart Failure Society of America, member
• International Society of Heart and Lung Transplantation, member

Selected Publications

Lee S, Kamdar F, Madlon-Kay R, Boyle A, Colvin-Adams M, Pritzker M, John R. Effects of the HeartMate II continuous-flow left-ventricular assist device on right-ventricular function. J Heart Lung Transplant 2010;29:209-215

Kamdar F, Boyle A, Liao K, Colvin-Adams M, Joyce L, John R. Effects of centrifugal, axial, and pulsatile left-ventricular assist device support on end-organ function in heart-failure patients. J Heart Lung Transplant 2009;28:352-359
 
Lietz K, Brown K, Ali SS, Colvin-Adams M, Boyle AJ, Anderson D, Weinberg AD, Miller LW, Park S, John R, Lazar RM. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left-ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg 2009;137:1012-1019
 
Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left-ventricular assist devices. J Thorac Cardiovasc Surg 2009;137:208-215
 
John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, Boyle A. Low thromboembolic risk for patients with the Heartmate II left-ventricular assist device. J Thorac Cardiovasc Surg 2008;136:1318-1323
 
John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left-ventricular assist device as bridge-to-transplant therapy. Ann Thor Surg 2008;86:1227-1235
 
Garcia S, Kamdar F, Boyle A, Colvin-Adams M, Liao K, Joyce L, John R. Effects of pulsatile- and continuous-flow left- ventricular assist devices on left-ventricular unloading. J Heart Lung Transplant 2008;27:261-267
 
John R, Liao K, Lietz K, Kamdar F, Colvin-Adams M, Boyle A, Miller L, Joyce L. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134:351-358
 
Colvin-Adams M, Taylor AL. Interpreting the African-American Heart-Failure Trial (A-HeFT): Isosorbide dinitrate-hydralazine improves outcomes in African-Americans with heart failure. Cleveland Clinic Journal of Medicine 2007;74(3):227-234
 
Boyle A, Colvin-Adams M. Recipient selection and management. Semin Thorac Cardiovasc Surg. 2004;16(4):358-363
 
de Marchena E, Colvin-Adams M, Esnard J, Ridha M, Castellanos A, Myerburg RJ. Ventriculophasic sinus arrhythmia in the orthotopic transplanted heart: mechanism of disease revisited. Int J Cardiol 2003;91:71-74